Commerzbank Aktiengesellschaft’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-50,102
| Closed | -$207K | – | 975 |
|
|
2016
Q4 | $207K | Buy |
50,102
+699
| +1% | +$2.89K | ﹤0.01% | 858 |
|
|
2016
Q3 | $400K | Buy |
49,403
+251
| +0.5% | +$2.03K | 0.01% | 612 |
|
|
2016
Q2 | $383 | Sell |
49,152
-1,334
| -3% | -$10 | ﹤0.01% | 738 |
|
|
2016
Q1 | $390K | Sell |
50,486
-368
| -0.7% | -$2.84K | ﹤0.01% | 750 |
|
|
2015
Q4 | $549K | Buy |
50,854
+1,484
| +3% | +$16K | ﹤0.01% | 736 |
|
|
2015
Q3 | $341K | Sell |
49,370
-2,713
| -5% | -$18.7K | ﹤0.01% | 821 |
|
|
2015
Q2 | $461K | Sell |
52,083
-30,962
| -37% | -$274K | ﹤0.01% | 897 |
|
|
2015
Q1 | $819K | Buy |
+83,045
| New | +$819K | ﹤0.01% | 747 |
|
|
2014
Q2 | – | Sell |
-10,355
| Closed | -$34K | – | 1143 |
|
|
2014
Q1 | $34K | Buy |
+10,355
| New | +$34K | ﹤0.01% | 1088 |
|
|
2013
Q3 | – | Sell |
-28,519
| Closed | -$233K | – | 1261 |
|
|
2013
Q2 | $233K | Buy |
+28,519
| New | +$233K | ﹤0.01% | 1154 |
|